BNTX240920C50000
- 49.00
- 0.000.00%
BioNTech Newsroom
BioNTech Price Target Raised to $150.00/Share From $95.00 by Deutsche Bank
BioNTech Is Maintained at Buy by Deutsche Bank
BioNTech Analyst Ratings
Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $150
UBS Maintains BioNTech(BNTX.US) With Hold Rating, Raises Target Price to $131
UBS Maintains Neutral on BioNTech, Raises Price Target to $131
BioNTech Price Target Raised to $150.00/Share From $96.00 by Jefferies
A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $125 to $171
BioNTech Analyst Ratings
Jefferies Upgrades BioNTech SE (BNTX) to a Buy
Evercore ISI Sticks to Its Hold Rating for BioNTech SE (BNTX)
BioNTech Price Target Raised to $150.00/Share From $125.00 by B of A Securities
BioNTech Is Maintained at Buy by B of A Securities
BioNTech SE (BNTX) Gets a Hold From TD Cowen
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $113 Price Target
BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $150
J.P. Morgan Upgrades BioNTech(BNTX.US) to Hold Rating, Announces Target Price $125
Buy Rating Affirmed for BioNTech SE Following Promising Clinical Trial Results in Oncology
BioNTech Is Maintained at Hold by Jefferies
BioNTech Analyst Ratings